Cx43-Associated Secretome and Interactome Reveal Synergistic Mechanisms for Glioma Migration and MMP3 Activation.
ARK1B10
MMP3
connexin43
gap junction
glioma
migration
osteopontin
secretome
Journal
Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481
Informations de publication
Date de publication:
2019
2019
Historique:
received:
27
09
2017
accepted:
07
02
2019
entrez:
4
4
2019
pubmed:
4
4
2019
medline:
4
4
2019
Statut:
epublish
Résumé
Extracellular matrix (ECM) remodeling, degradation and glioma cell motility are critical aspects of glioblastoma multiforme (GBM). Despite being a rich source of potential biomarkers and targets for therapeutic advance, the dynamic changes occurring within the extracellular environment that are specific to GBM motility have yet to be fully resolved. The gap junction protein connexin43 (Cx43) increases glioma migration and invasion in a variety of
Identifiants
pubmed: 30941001
doi: 10.3389/fnins.2019.00143
pmc: PMC6433981
doi:
Types de publication
Journal Article
Langues
eng
Pagination
143Références
Brain Res Brain Res Rev. 2000 Apr;32(1):259-66
pubmed: 10751676
J Biol Chem. 2000 Aug 25;275(34):26411-5
pubmed: 10827175
J Biol Chem. 2001 Jul 27;276(30):28261-7
pubmed: 11375993
Int J Cancer. 2001 Oct 15;94(2):153-6
pubmed: 11668491
J Biol Chem. 2002 Mar 22;277(12):10482-8
pubmed: 11790776
J Neurosci. 2002 Jun 1;22(11):4302-11
pubmed: 12040035
Nat Rev Mol Cell Biol. 2002 Jul;3(7):509-19
pubmed: 12094217
Cell Tissue Res. 2002 Dec;310(3):257-70
pubmed: 12457224
Exp Cell Res. 2002 Dec 10;281(2):197-204
pubmed: 12460650
Cancer Res. 2003 May 15;63(10):2409-15
pubmed: 12750260
J Cell Biol. 1992 Jul;118(1):195-201
pubmed: 1320034
Cancer Res. 1992 Aug 1;52(15):4208-13
pubmed: 1322238
Acta Neurochir Suppl. 2003;88:153-62
pubmed: 14531573
Eur J Neurosci. 2003 Oct;18(8):2313-8
pubmed: 14622192
Lab Invest. 2004 Jan;84(1):8-20
pubmed: 14631378
Anal Chem. 2003 Dec 15;75(24):6843-52
pubmed: 14670044
J Neurosurg. 2003 Dec;99(6):1039-46
pubmed: 14705732
Cardiovasc Res. 2004 May 1;62(2):233-45
pubmed: 15094344
J Biol Chem. 2004 Aug 27;279(35):36943-50
pubmed: 15213231
J Neurooncol. 2004 Nov;70(2):217-28
pubmed: 15674479
BMC Cell Biol. 2005 Feb 16;6(1):7
pubmed: 15715906
J Biol Chem. 2005 May 20;280(20):19925-36
pubmed: 15741167
Int J Mol Med. 2005 May;15(5):771-6
pubmed: 15806297
Clin Exp Metastasis. 2005;22(3):237-46
pubmed: 16158251
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D535-9
pubmed: 16381927
Neurosci Lett. 1991 May 13;126(1):33-6
pubmed: 1650934
Biophys J. 2006 Oct 1;91(7):2708-16
pubmed: 16829558
Biochim Biophys Acta. 2007 May;1773(5):642-52
pubmed: 16926057
J Proteome Res. 2006 Sep;5(9):2123-34
pubmed: 16944923
Cell Motil Cytoskeleton. 2007 Feb;64(2):121-30
pubmed: 17183550
Cell Mol Life Sci. 2007 Feb;64(4):458-78
pubmed: 17260089
Cancer Res. 2007 Apr 15;67(8):3691-7
pubmed: 17440081
Nature. 2007 Aug 23;448(7156):901-7
pubmed: 17713529
Glia. 2007 Nov 15;55(15):1554-64
pubmed: 17823969
Genes Dev. 2007 Nov 1;21(21):2683-710
pubmed: 17974913
J Cell Biochem. 2008 Apr 15;103(6):1772-82
pubmed: 18004727
Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20764-9
pubmed: 18087047
FEBS Lett. 2008 Jun 18;582(14):2102-11
pubmed: 18396168
Curr Protoc Immunol. 2001 May;Appendix 3:Appendix 3B
pubmed: 18432654
Curr Cancer Drug Targets. 2008 May;8(3):172-9
pubmed: 18473730
Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1883-7
pubmed: 1848013
Cancer Res. 2008 Sep 15;68(18):7247-9
pubmed: 18794108
Proteomics. 2008 Nov;8(22):4624-32
pubmed: 18850632
Nat Biotechnol. 2008 Dec;26(12):1367-72
pubmed: 19029910
Cancer Res. 2009 May 15;69(10):4167-74
pubmed: 19435897
Cell. 2009 Nov 25;139(5):891-906
pubmed: 19931152
Trends Cell Biol. 2010 Feb;20(2):92-101
pubmed: 19944606
Science. 2009 Nov 27;326(5957):1208-12
pubmed: 19965462
Mol Cell Proteomics. 2010 Jun;9(6):1100-17
pubmed: 20124221
Neuro Oncol. 2010 Jan;12(1):58-70
pubmed: 20150368
J Cell Biochem. 2010 Jun 1;110(3):589-97
pubmed: 20512920
Anal Bioanal Chem. 2010 Sep;398(1):477-87
pubmed: 20577720
Cancer Biol Ther. 2010 Oct 15;10(8):796-810
pubmed: 20686364
Anticancer Drugs. 2011 Jun;22(5):402-8
pubmed: 21317765
Dis Model Mech. 2011 Mar;4(2):165-78
pubmed: 21324931
J Proteome Res. 2011 Jul 1;10(7):3149-59
pubmed: 21574646
J Proteomics. 2011 Sep 6;74(10):1918-25
pubmed: 21601021
Nat Methods. 2011 Sep 29;8(10):785-6
pubmed: 21959131
Biochim Biophys Acta. 2012 Aug;1818(8):2058-67
pubmed: 22063721
Biochim Biophys Acta. 2012 Aug;1818(8):1993-2001
pubmed: 22155212
Front Pharmacol. 2012 Jan 31;3:5
pubmed: 22319498
J Cell Biol. 2012 Feb 20;196(4):395-406
pubmed: 22351925
J Oncol. 2012;2012:351089
pubmed: 22481923
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Cancer Lett. 2013 Jan 28;328(2):235-42
pubmed: 23022473
J Proteome Res. 2012 Dec 7;11(12):6134-46
pubmed: 23106098
Mol Biosyst. 2013 Jun;9(6):1390-400
pubmed: 23483059
Neuropharmacology. 2013 Dec;75:539-48
pubmed: 23688923
Bioinformatics. 2014 Feb 15;30(4):523-30
pubmed: 24336805
Cell Death Dis. 2014 Mar 27;5:e1145
pubmed: 24675463
Proteomics. 2014 Jun;14(12):1494-502
pubmed: 24729417
Genes Dev. 2014 Nov 1;28(21):2331-47
pubmed: 25367033
PLoS One. 2014 Dec 29;9(12):e116210
pubmed: 25545242
Matrix Biol. 2015 May-Jul;44-46:122-9
pubmed: 25636538
Cancer Epidemiol. 2015 Apr;39(2):135-42
pubmed: 25677090
Database (Oxford). 2015 Jun 14;2015:bav051
pubmed: 26078477
PLoS One. 2015 Aug 13;10(8):e0135544
pubmed: 26270045
Matrix Biol. 2016 Jan;49:37-60
pubmed: 26407638
Cancer Res. 2016 Jan 1;76(1):139-49
pubmed: 26542214
Semin Cell Dev Biol. 2016 Feb;50:59-66
pubmed: 26706148
Recent Pat Anticancer Drug Discov. 2016;11(2):184-96
pubmed: 26844556
Oncotarget. 2016 Apr 5;7(14):18458-68
pubmed: 26918342
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Proteomics. 2016 Aug;16(15-16):2160-82
pubmed: 27302376
Arch Gynecol Obstet. 2017 Mar;295(3):689-696
pubmed: 27995372
Cancer Cell. 2017 Mar 13;31(3):326-341
pubmed: 28292436
Methods Mol Biol. 2017;1611:59-73
pubmed: 28451972
Mass Spectrom Rev. 2017 Jul 9;:
pubmed: 28691345
Int J Oncol. 2018 Jan;52(1):295-304
pubmed: 29115581
Int J Mol Sci. 2018 Jan 04;19(1):null
pubmed: 29300332
Methods Mol Biol. 2018;1711:133-148
pubmed: 29344888
Curr Opin Pharmacol. 2018 Aug;41:79-88
pubmed: 29803991
J Biol Chem. 1994 Aug 19;269(33):20952-7
pubmed: 8063713
Exp Cell Res. 1993 May;206(1):72-84
pubmed: 8387023
Int J Cancer. 1996 Jul 17;67(2):275-82
pubmed: 8760599
Neurosurgery. 1996 Aug;39(2):235-50; discussion 250-2
pubmed: 8832660
J Cell Sci. 1996 Mar;109 ( Pt 3):643-52
pubmed: 8907709
Annu Rev Cell Dev Biol. 1996;12:697-715
pubmed: 8970741
Cancer Res. 1998 Nov 15;58(22):5089-96
pubmed: 9823317
J Cell Biol. 1998 Dec 14;143(6):1725-34
pubmed: 9852163
J Cell Biochem Suppl. 1998;30-31:92-102
pubmed: 9893260